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post-surgical follow-up of 87 patients with 
non-functioning pituitary macroadenomas
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macroadenomas hipofisários não funcionantes
Paulo Andrade de Mello1, Luciana Ansaneli Naves2, Aldo Pereira Neto1, Eduardo Henrique Oliveira³, 
Ivan Coelho Ferreira3, Antônio Santos de Araújo Júnior3, Franz Jooji Onishi3, Luiz Augusto Casulari4 
Pituitary tumors may be associated with significant 
morbidity, above all due to the compression effects on ad-
jacent structures and endocrine effects from excessive pro-
duction or hormone deficiency1-3. Pituitary tumors can be 
classified according to their ability to produce hormones 
(secreting or non-secreting adenomas), defined in terms of 
their clinical and hormonal elevation or from immunohis-
tochemical analysis1-3.
Clinically, non-functioning tumors lead to a silent clini-
cal outcome, but can express functional capacity through 
immunohistochemistry, relating to frustrated production of 
peptides or their biochemical fractions, with no biological 
action4-7. Attempts to correlate certain markers with path-
ological potential have had no effect: expression of recep-
tors for epidermal growth factor5, Ki-67 antibodies with pro-
liferative potential and C-erb-B27 did not correlate with 
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AbstrACt
Objective: It was to assess the main characteristics of patients undergoing pituitary tumor surgery. Method: Eighty-seven patients (44 men; 
44.8±13 years old) were included. Results: The main symptoms were visual alterations (87.3%), headache (70.1%), diminished libido (34.4%), 
galactorrhea (22.9%) and hair loss (19.5%). The axes affected were gonadotropic (72.6%), thyrotropic (48.4%) and corticotropic (38.7%), with-
out significant changes after surgery. The average largest tumor diameter was 3.1 cm before surgery and 1.56 cm after surgery. The most 
frequent postoperative complications were hydro-electrolyte and acid-base disorders (12%), diabetes insipidus (9%), visual field alterations 
(9%), liquoric fistula (8%) and nasal obstruction (7%). The patients were affected by more than one complication. Conclusion: Although a de-
crease in tumor volume was achieved through surgery, hormonal deficiencies persisted in most of the patients and new surgical approaches 
were necessary for dealing with tumor recurrence or persistence.
Key words: pituitary neoplasms, neurosurgery, hormone, insufficient, pituitary adenomas, hypopituitarism.
resumo
Objetivo: Avaliar as principais características de pacientes operados de tumor de hipófise. Método: Foram incluídos 87 pacientes 
(44 homens; 44,8±13 anos). Resultados: Os principais sintomas foram alterações visuais (87,3%), cefaleia (70,1%), diminuição da 
libido (34,4%), galactorreia (22,9%) e queda de pelos (19,5%). Os eixos afetados foram gonadotrófico (72,6%), tireotrófico (48,4%) 
e corticotrófico (38,7%). Não houve mudanças significativas após a cirurgia. A média do maior diâmetro do tumor foi 3,1 cm an-
tes da cirurgia e 1,56 cm após a cirurgia. As complicações pós-cirúrgicas mais frequentes foram distúrbios hidroeletrolíticos e 
ácido-básicos (12%), diabetes insipidus (9%), alterações do campo visual (9%), fístula liquórica (8%) e obstrução nasal (7%). Ocor-
reu mais de uma complicação no mesmo paciente. Conclusão: Embora tenha obtido diminuição da massa tumoral com a cirurgia, 
as deficiências hormonais persistiram na maioria dos pacientes e ocorreu necessidade de novas abordagens por recidiva ou per-
sistência do tumor.
Palavras-Chave: neoplasia hipofisária, neurocirurgia, insuficiência, hormônio, adenomas hipofisarios, hipopituitarismo.
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the various biological aspects of non-functioning tumors. 
They also showed particular characteristics in relation to ex-
pression of receptors for somatostatin or for dopamine ago-
nists because the response to pharmacological treatment is 
variable and dependent on the subtype of each receptor and 
its degree of expression in the tumor tissue6.
Since these tumors have no specific clinical outcome result-
ing from hormonal hypersecretion, they are usually recognized 
late and present large lesions with complex surgical manage-
ment7,8. Their main signs and symptoms result from compres-
sion of surrounding structures, such as optic chiasm, thus caus-
ing bitemporal hemianopsia and destruction of pituitary cells, 
which results in varying deficits of hormonal secretion1,2,9.
The objective of this study was to present a sample of 
cases of non-functioning tumors that received surgical treat-
ment at the University Hospital of Brasília. The main clini-
cal and laboratory characteristics and surgical procedures, 
as well as the numbers of interventions and complications, 
were evaluated.
metHoD
This was an observational, descriptive and retrospec-
tive case study, in which patients operated at the Hospital 
Universitário de Brasília (HUB) between 1990 and 2006 were 
evaluated. Information was obtained from medical records, 
interviews and patient reviews at the neuroendocrinology 
outpatient clinics.
The inclusion criteria were that the patients should pres-
ent a non-functioning pituitary adenoma defined by the ab-
sence of signs and symptoms of hormonal hypersecretion; 
the hormonal serum LH, FSH, TSH, cortisol, GH, IGF-1 and 
prolactin levels; or functional tests showing no excess hor-
mones. The prolactin levels were the exception, which in 
some patients showed small increases due to compression of 
the pituitary stalk10,11.
Patients with adenomas that through clinical and laborato-
ry tests seemed to secrete pituitary hormones were excluded.
The hormone deficiency criterion was based on the pres-
ence of signs and symptoms of hormone deficiency and se-
rum hormone measurements below normal values, accord-
ing to the method used. Thyroid hormone deficiency was 
taken to be present when the level of free T4 was below 
1 ng/mL. TSH was not considered for the diagnosis because 
production of this immunologically active hormone is com-
mon: it is recognized by the dosage test, but is biologically 
inactive12. Cortisol deficiency was taken to be present when 
the blood level was below 8 μg/dL at 8 o’clock in the morn-
ing, with or without signs and symptoms that might be as-
sociated with cortisol deficiency, i.e. weakness, asthenia, 
weight loss, postural hypotension, nausea and vomiting, di-
arrhea and myalgia13. In women, deficiency of gonadotropin 
secretion was defined by presence of amenorrhea before the 
age of menopause, decreased libido, and FSH, LH and estra-
diol levels different from those recommended for the age 
and menstrual cycle phase, according to the testing meth-
ods used at the time13. In men, gonadotropin deficiency was 
taken to be present when there was decreased libido and al-
tered FSH, LH and total and free testosterone levels, in rela-
tion to those recommended for the age range14,15. No assess-
ment was made of the routine GH axis, because this study 
was not directed towards hormone replacement given that 
the patients were adults. The tests for hormone levels were 
in the first cases measured by means of radioimmunoassay 
and, more recently, by immunoassay.
The sizes of the tumors in the first cases that were operat-
ed were measured on the image of the sella turcica  obtained 
by means of computed tomography, with contrast in the 
anteroposterior plane. For more recent cases, images ob-
tained by means of magnetic resonance on the sellar region 
with contrast were used.
The surgery on the first cases was performed by one of the 
neurosurgeon authors (Paulo Andrade de Mello) and, after 1996, 
another neurosurgeon (Aldo Pereira Neto) also participated.
The surgery consisted of a sublabial transseptal-trans-
sphenoidal approach using a microscope described by 
Hardy, with some modifications16,17. In cases in which the tu-
mor could not be removed, another new surgery procedure 
was carried out using either this approach or a transcranial 
one18. At the beginning of the series, a small number of pa-
tients were initially treated by means of a transcranial ap-
proach. In the immediate postoperative period, all patients 
were in the intensive care unit.
The statistical analysis was performed using Fisher’s 
exact test or the χ2 test for categorical variables and 
Student’s t-test for continuous data with normal distribu-
tion. The  p≤0.05 was taken to be statistically significant. 
The results were presented as means and standard devia-
tions and percentages.
resuLts
During the study period, 150 patients with pituitary 
macroadenomas were operated and had the following di-
agnoses: 91 (60.6%) with clinically non-functioning tumors, 
40 (26.6%) with GH secretion, nine (6.0%) with prolactino-
mas, five (3.3%) with Cushing’s disease and five (3.3%) with 
gonadotropin secretion.
Eighty-seven patients diagnosed with non-function-
ing pituitary adenoma were selected, since no detailed 
information was available on four patients, with no out-
patient follow-up.
The patient distribution according to sex showed simi-
lar proportions: 44 men and 43 women. The average age at 
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the time of the first surgery was 44.8 years (SD=13), with 
extremes of 19 and 80 years of age. The vast majority of the 
patients were in the age range between 30 and 49 years 
(56.5%). The average ages of the males (45.3 years; SD=13.4) 
and females (44.1 years; SD=12.7) were similar. 
The median follow-up period was 3.5 years, with a range 
from 6 months to 26 years. 
The frequencies of initial manifestations are shown in 
Fig 1. It was observed that visual alterations were the most 
frequent (87.3%), followed by headache (70.1%), decreased 
libido (34.4%), galactorrhea (22.9%) and hair loss (19.5%). 
Galactorrhea, arthralgia and headache were more frequent 
only among women, while sweating and visual alterations 
were more frequent among men (p<0.05).
The distribution of patients’ operations to surgical ap-
proach (either transsphenoidal or transcranial) and the 
number of surgeries is shown in Table 1. The transsphe-
noidal approach was initially adopted in 92% of the cases, 
and the transcranial approach in 8% of the cases. However, 
it was observed that, when new approaches were needed, 
the transsphenoidal approach was increasingly replaced 
by the  transcranial technique. Among the 87 patients op-
erated, 32 (36.7%) of them had to undergo a second pro-
cedure, and a percentage higher than in the first operation 
(n=13 [30.9%]) underwent the transcranial approach. Five 
patients (5.7%) underwent a third surgical procedure: one 
using the transsphenoidal technique and four using the 
transcranial technique (Table 1).
As shown in Table 2, the mean largest tumor diameter 
was 3.10 cm before surgery and 1.56 cm after surgery, with no 
significant difference between the men and women.
The surgical treatment was correlated with several com-
plications, as shown in Table 3. The most frequent were hydro-
electrolytic and acid-base disturbances, diabetes insipidus, vi-
sual field alterations, liquoric fistula and nasal obstruction. 
There were two deaths (3%) during the postoperative period 
of patients with tumors of large proportions. Some patients 
presented more than one complication. 
Fig 2 shows the hormonal assessments before surgery 
and over the long-term follow-up of the patients. It was ob-
served that, before surgery, the gonadotropic axis was the 
most affected (73%), followed by the thyrotropic axis 
(48%) and corticotropic axis (39%). Surgical treatment did 
not alter the deficits already present, with the exception of 
the corticotropic axis, in which more patients had deficits 
after surgery. Most patients remained indefinitely depen-
dent on hormonal supplementation in relation to the af-
fected axis.
Twenty-four patients (27%) received adjuvant radiothera-
py: 13 of them were male and 11 female.
Table 1. Distribution of patients undergoing to pituitary tumor surgery, according to the surgical technique.
TSE: transsphenoidal surgery; TSC: transcranial surgery.
First surgery Second surgery Third surgery 
TSE TSC TSE TSC TSE TSC
Male 39 4 10 7 1 2
Female 41 3 9 6 0 2
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Fig 1. Frequencies of initial manifestations of the 87 patients with pituitary tumors.
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adequately to drug use1-3. However, it was recently reported 
that temozolomide may be useful for treating a few aggres-
sive non-functioning tumors19.
The frequency was similar between the sexes, which is in 
agreement with other samples20, but higher prevalence among 
men has also been described5. As reviewed by Yamada8, other 
immunohistochemistry-based studies showed predominance 
of men over women in silent gonadotropic cases and of women 
over men in silent adrenocorticotropic cases.
One of the clinical characteristics of non-functioning tu-
mors is the higher frequency of diagnosis among the elder-
ly5. It has been reported that 80% of pituitary tumors in the 
elderly over 65 years of age are non-secreting21. In this sam-
ple, most of the patients were over 40 years of age (61.7%). 
This can be explained, at least in part, by the delayed diagno-
sis caused by lower frequency of symptoms and signs relating 
to hormone secretion1,2. The slow progressive development of 
a lesion without functional indicators that would facilitate 
diagnosis seems to have led to two basic types of complaints 
among these patients: headache and visual disturbances. 
These symptoms have also been reported by other patients 
at the time of diagnosis20,22. Visual changes were present in 
87.3% of the patients, given that the study population had 
only been referred to the hospital when they showed large 
lesions (average size of 3.1 cm). Regarding the high incident 
of headaches (70.1%), there may have been other explana-
tions apart from the tumor size. As reviewed recently23, the 
frequency has varied over a range from 33 to 72%, with sev-
eral forms of presentation. Headaches relating to tumors of 
Table 2. Tumor diameter before and after surgery.
*p=0.75 versus female; †p=0.99 versus female.
Before After p-value
Male 3.16±1.18* 1.65±1.4† 0.0004
Female 3.05±1.02 1.65±0.74 0.0009
Table 3. Complications relating to surgical treatment on 87 
patients with pituitary tumors.
*Several patients presented more than one complication.
Complication n (%)*
Hydro-electrolyte and acid-base disorders 10 (12)
Diabetes insipidus 8 (9)
Visual field alteration 8 (9)
Liquoric fistula 7 (8)
Nasal obstruction 6 (7)
Ophthalmoplegia 4 (5)
Headache 4 (5)
Paresis or plegia 4 (5)
Meningitis 4 (5)
Sepsis and/or hospital infection 4 (5)
Deaths 2 (3)











The present sample consisted only of non-functioning tu-
mors, which represented 60.6% of pituitary tumors operat-
ed at UHB over the study period. The tumors most indicated 
for surgery are non-functioning, since they do not respond 
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the hypophysis may involve pressure mechanisms on some 
structures, as well as a neuroendocrine origin. This has been 
discussed in detail by Freitas at al.23.
Pituitary apoplexy9,24 may be a form of presentation. 
Tumor presence is often discovered incidentally20.
The basic principles of surgical management of tumors 
involving the pituitary gland include relieving the pressure 
on neighboring structures, particularly the visual structures, 
normalization of hypersecretion, preservation or restoration 
of pituitary function, prevention of tumor recurrence and 
collection of tissue for pathological and functional study18.
These principles gain importance in the case of non-func-
tioning adenomas, due to their complexity, which is primarily 
related to tumor size7. Monitoring the tumor volume before 
and after surgery showed that our patients’ tumor size re-
duced on average from 3.1 to 1.56 cm, which suggests that for 
most of the patients treated only partial tumor removal was 
achieved. The fact that most of the patients were older, with 
large lesions and complex symptoms, guided the approach 
used and extent of surgical removal among these patients, in 
order not to produce new hormone deficiencies and injuries 
to important structures surrounding the tumor.
Most of the patients were operated by means of the 
transsphenoidal and transseptonasal techniques using  a 
surgical microscope (Table 2). However, there has been 
a trend towards using transnasal endoscopy in healthcare 
services in Brazil25-27 and abroad28,29. One of the advantages of 
using an endoscope would be the better viewing and resec-
tion of residual tumors due to the possibility of introducing 
the endoscope into the sella turcica and suprasellar region, 
which would facilitate the surgical cure29. Moreover, this 
might prevent bleeding in the cavernous sinus and lesions 
in the internal carotid artery28. These advantages would not 
be possible with the surgical microscope26-29. However, in 
operations on functioning tumors, Barbosa et al.25 found no 
statistical differences in the results obtained with the two 
techniques. Total or near total removal of 83% of 93 non-
functioning adenomas operated using solely the endona-
sal technique has recently been described26. Similar results 
were obtained with a small sample of 30 patients27. It is pos-
sible that the differences between what we obtained with 
our sample and the previous results were due to differences 
in the surgical techniques used.
The determining factor for signs and symptoms of com-
pression is the pressure effect on neighboring structures. 
The immediate relief achieved through surgery seems to be 
directly related to the reduced intratumoral pressure30-32. In 
our sample, this was achieved through reduction of tumor 
volume and, more exceptionally, tumor exclusion. This dif-
ficulty in achieving tumor cure through surgery was also ob-
served in 295 patients with non-functioning tumors, among 
whom this was achieved in only 35.5%22. Recurrence occurred 
in 19.2% of those who had no residual tumor after a mean of 
seven years after the surgery and in 58% of those with tumor 
residues after an average of five years. For the patients who 
received radiotherapy, the recurrence rate was 18.4% within 
eight years22.
Hormone deficiency at the time of diagnosing a non-
functional tumor is frequently observed20. The cases report-
ed here had significant preoperative involvement in the go-
nadal, thyrotropic and corticotropic axes (Fig 2). The gonadal 
axis was also the one most frequently affected in other sam-
ples22. These axes remained affected and justified long-term 
replacement therapy. Although it could be inferred that re-
lief of tumor compression after surgery could partially restore 
the affected pituitary axes, this expected result was not con-
firmed. This was also observed by other authors20.
Surgery on large pituitary tumors was related to several 
complications, mostly of short duration (Table 1). Several pa-
tients presented more than one complication. Hydro-
electrolyte and acid-base disorders occurred most frequently, 
and most were related to the presence of diabetes insipidus. 
The prevalence of diabetes insipidus after surgery using the 
endonasal endoscopic technique has been described as 3.526, 
1520 and 20%25, but most cases were transient, as occurred 
with 9% of the cases operated in this study.
Liquoric fistula was present in 8% of the surgical patients 
and in many of them, fat grafting was used to prevent fistula, 
which in other studies would not have been the best choice27. 
All of these cases were treated with cerebrospinal fluid 
drainage only. Meningitis was present in 5% of the patients 
and required intensive antibiotic treatment. Meningitis was 
caused by liquoric fistula. Using only the endonasal tech-
nique, the presence of fistula has been described as 3.526 and 
16%27. Of the cases, 77% were operated with this technique. 
The rest were operated with the aid of a microscope, and fis-
tula occurred only in 10%, but no meningitis was observed 
as a complication.
Other complications observed after surgery (Table 3) 
were described in patients with large tumors, in which mor-
bidity was very common3.
There were two deaths (3%) during the postoperative pe-
riod of patients with macroadenomas and large expansions, 
but it was not possible to obtain postmortem examinations 
to clarify the cause. However, the cause was suspected to be 
related to surgical management.
The long follow-up on the patients operated (4.5 years) sug-
gested that most of them can live with residual tumors, pro-
vided that they are continually monitored, with replacement 
therapy administered to the major pituitary axes. Follow-up 
on patients with non-functioning pituitary tumors is neces-
sary because it has been reported that 34.8% of such cases 
present increased tumor size after a mean time of 6.1 years 
after surgery. Using Kaplan-Meier analysis, the relapse rate 
was 23.1% after five years, 46.7% after 10 years and 67.9% after 
15 years. Moreover, when a tumor regrowth rate was present 
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after surgery, it was significantly higher (p<0.001) than in pa-
tients with no tumor remains33. Similar results were observed 
by other authors20. However, this behavior is different from 
non-functioning tumors that are not selected for surgery, 
which in the majority (83%) of cases remain stable in size9,20.
In conclusion, a significant reduction of tumor volume 
was achieved through surgery, but the hormonal deficien-
cies persisted in most of the patients. This led to the need for 
new approaches due to recurrence or persistence of tumor 
remains after the first surgery. 
